Loss of viral control in early HIV-1 infection is temporally associated with sequential escape from CD8+ T cell responses and decrease in HIV-1-specific CD4+ and CD8+ T cell frequencies.
暂无分享,去创建一个
Edward C Holmes | Annette Oxenius | A. Trkola | E. Holmes | P. Easterbrook | A. Oxenius | R. Phillips | E. Gostick | A. Waters | David A Price | Emma Gostick | Alexandra Trkola | Philippa J Easterbrook | Anele Waters | Hua-Tang Zhang | Rodney E Phillips | Charles Edwards | Tin Tun | Andrew Johnson | T. Tun | Hua-tang Zhang | D. Price | C. Edwards | Andrew Johnson
[1] G. Shaw,et al. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection , 1994, Journal of virology.
[2] A. Trkola,et al. A Cell Line-Based Neutralization Assay for Primary Human Immunodeficiency Virus Type 1 Isolates That Use either the CCR5 or the CXCR4 Coreceptor , 1999, Journal of Virology.
[3] John W. Mellors,et al. Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.
[4] Philip J. R. Goulder,et al. Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.
[5] D. Richman,et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. , 1997, Science.
[6] R. Koup,et al. Expression and characterization of CD4-IgG2, a novel heterotetramer that neutralizes primary HIV type 1 isolates. , 1995, AIDS research and human retroviruses.
[7] A. Trkola,et al. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1 , 1996, Journal of virology.
[8] M. Barnardo,et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). , 1995, Tissue antigens.
[9] P. Easterbrook,et al. Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[10] V. Maino,et al. The CD4(+) T cell response to HIV-1. , 2000, Current opinion in immunology.
[11] G Himmler,et al. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1 , 1993, Journal of virology.
[12] R. Phillips,et al. Escape of human immunodeficiency virus from immune control. , 1997, Annual review of immunology.
[13] S. Rowland-Jones,et al. Cellular immune responses to HIV , 2001, Nature.
[14] A. Oxenius,et al. Cytotoxic T Lymphocyte Responses to Human Immunodeficiency Virus: Control and Escape , 2000, Stem cells.
[15] S. Hammer,et al. Host Determinants in HIV Infection and Disease: Part 2: Genetic Factors and Implications for Antiretroviral Therapeutics* , 2001, Annals of Internal Medicine.
[16] J. Mellors,et al. Quantitation of HIV-1 RNA in Plasma Predicts Outcome after Seroconversion , 1995, Annals of Internal Medicine.
[17] R. Desrosiers,et al. Viral persistence: HIV's strategies of immune system evasion. , 2002, Annual review of medicine.
[18] D. Ho,et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome , 1994, Journal of virology.
[19] Z. Grossman,et al. HIV preferentially infects HIV-specific CD4+ T cells , 2002, Nature.
[20] M. Daucher,et al. Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infection. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[21] D R Burton,et al. In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivity. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[22] D. McPhee,et al. Rapid full-length genomic sequencing of two cytopathically heterogeneous Australian primary HIV-1 isolates. , 2000, Journal of biomedical science.
[23] Miles P. Davenport,et al. HIV-1 Variation Diminishes CD4 T Lymphocyte Recognition , 1998, The Journal of experimental medicine.